Analysts Offer Predictions for Immunovant, Inc.’s FY2026 Earnings (NASDAQ:IMVT)

Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Equities researchers at Leerink Partnrs dropped their FY2026 EPS estimates for shares of Immunovant in a note issued to investors on Monday, September 9th. Leerink Partnrs analyst T. Smith now forecasts that the company will earn ($2.82) per share for the year, down from their prior forecast of […]

Leave a Reply

Your email address will not be published.

Previous post Magnachip Semiconductor (NYSE:MX) Rating Increased to Hold at Barclays
Next post FY2025 EPS Estimates for Mama’s Creations, Inc. (NASDAQ:MAMA) Reduced by Roth Capital